Search results
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC Universal via AOL· 2 days agoBy attaching a chemotherapy drug to an antibody, doctors are able to deliver more potent...
Harry to Skip Billionaire Pal’s Wedding for a Reason: Report
The Daily Beast· 8 hours agoPrince Harry won’t be attending his friend’s lavish wedding in northwest England on Friday. Hugh...
Women denied ‘wonder drug’ that could double terminal breast cancer life expectancy
Daily Telegraph· 1 day agoWomen with HER2-low or ultra-low breast cancer who took Enhertu lived without their cancer growing...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Morningstar· 4 days agoInvestigational chemotherapy-free regimen of RYBREVANT® plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease ...
Cancer patients often do better with less intensive treatment, new research finds
WSB Radio· 2 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Veteran Millersville golf coach using sport to power him through his third cancer battle
Lancaster Online· 1 day agoUsually it’s so he can participate in an annual golf outing, held in memory of his wife, Deborah...
‘There Is No Ethan’ Is a Jaw-Dropping Tale of Digital Deception
New York Times· 6 hours agoReading Anna Akbari’s memoir of online manipulation, you think you’ve seen it all — then you keep...
'I'd be dead by now': Canadians share breast cancer stories as new screening guidelines spark...
Yahoo Canada Style· 6 hours agoAlthough a federal task force says mammograms shouldn't be routine for women under 50, new data...
How a new South Florida cancer salon helps people heal and get ‘back to their lives’
Miami Herald via Yahoo News· 3 days agoVictoria Trujillo-Cortellese lost her waist-long, salt-and-pepper hair to six rounds of chemotherapy...
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on...
Morningstar· 3 days agoSeparate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of Patients Previously Receiving 3rd Generation EGFR-TKI: PFS Hazard Ratio of 0.48 5.